Tissue viability
The way forward The pandemic necessitated delivering care differently, and many services rose to the challenge. Many more patients have been supported to self-care, requiring fewer face-to- face visits. Having lifted the barriers to support self-care and telemedicine, it is also recognised that these modes of care delivery will not suit all patients. Self-care cannot mean support and good shared-care systems are no longer needed. There is some evidence that the geographic
areas that have adapted best are those with well-resourced tissue viability and community care services that are already offering advanced care. However, the need to do things differently has led to a broader cultural shift, with more assessments and consultations by telephone and video calls, and more patients supported to self-care. These changes are likely to endure and grow well after the pandemic and will accelerate the redesign of services.
CSJ
References 1 Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018;22:18- 033. doi: 10.7812/TPP/18-033. PMID: 30005722; PMCID: PMC6045499.
2 Phillips, CJ, Humphreys, I, Thayer, D, et al.
Cost of managing patients with venous leg ulcers. Int Wound J. 2020; 17: 1074– 1082. https://
doi.org/10.1111/iwj.13366
3
https://www.nhs.uk/conditions/leg-ulcer/ 4 Parker,C. Predicting the Likelihood of Delayed Venous Leg Ulcer Healing and Recurrence: Development and Reliability Testing of Risk Assessment Tools, Wound Mmt and Prevention. Volume 63 - Issue 10 - October 2017 ISSN 1943- 2720
5 Finlayson K, Edwards H, Courtney M. The impact About the author
Bernard Ross is CEO and founder of Sky Medical Technology (Sky). Bernard is a serial entrepreneur with more than 20 years’ senior experience at private and public board level across multiple industries including pharmaceutical, technology development and FMCG. Sky Medical Technology manufactures the geko device – a wristwatch-sized wearable applied to the knee delivering painless electrical impulses to stimulate blood flow, without the patient having to move. It has been globally adopted into healthcare systems to treat a range of medical conditions such as the
of psychosocial factors on adherence to compression therapy to prevent recurrence of venous leg ulcers. J Clin Nurs. 2010 May;19(9- 10):1289-97. doi: 10.1111/j.1365-2702.2009.03151.x. PMID: 20500338.
6 Weller CD, Richards C, Turnour L, Team V. Patient Explanation of Adherence and Non- Adherence to Venous Leg Ulcer Treatment: A Qualitative Study. Front Pharmacol. 2021 Jun 3;12:663570. doi: 10.3389/fphar.2021.663570. PMID: 34149416; PMCID: PMC8209379.
prevention of blood clots. Bernard is a former head of international development at CMI plc, senior vice president, cardiovascular of Bioaccelerate Inc. (BACL) and former CEO of Innacardio Inc.
Hip Instrumentation & Service we’ve got it covered
Need to restock your hip instrumentation?
We’re proud to present a selection of our reusable instrumentation which may be suitable for the compilation of your hip surgery sets. The sets can be tailored to your requirements.
We also offer a full repair and refurbishment service, ensuring you can use these high quality instruments for many, many years to come.
Scan the QR code to download our catalogue or get in touch to request a printed copy
Approved UK distributors of key international brands BOOKWALTER®
authorised distributor Proud to be a family-run British company +44 (0)1702 602050 |
info@surgicalholdings.co.uk |
surgicalholdings.co.uk August 2023 I
www.clinicalservicesjournal.com 55
WE ALL HAVE AN TO REFURBISH
ETHICAL DUTY OUR MEDICAL INSTRUMENTS
Hip Instruments Catalogue
Specialists in the repair and
refurbishment of rigid endoscopes and orthopaedic power tools
Promoting education; sharing knowledge and
Proud to be a family-run British company E.
info@surgicalholdings.co.uk off ering training opportunities T. +44 (0)1702 602050
surgicalholdings.co.uk
instruments are always in stock, ready to ship 10,000 products in stock
Our most popular general surgery reusable
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
